Drugs as Indicators of Hepatic Function
- 1 January 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 2 (1), 97S-105S
- https://doi.org/10.1002/hep.1840020115
Abstract
It is well recognized that liver disease may influence the disposition of many drugs. Conversely, it has been suggested that knowledge of the disposition of a model drug might provide an index of certain aspects of hepatic function. This review discusses the physiology of drug disposition and indicates how recent progress in understanding the determinants of drug disposition has provided useful indices of individual aspects of hepatic function. Topics which are discussed are the interpretation of pharmacokinetic parameters as indices of hepatic function, including half-life clearance, and intrinsic clearance. Utilizing the “intact hepatocyte hypothesis” as an operational model, an approach is described that uses the pharmacokinetic disposition of high and low intrinsic clearance drugs following p.o. and i.v. administration to provide quantitative estimates of hepatic function, flow to functioning hepatocytes, and the extent of portasystemic shunting through the liver. Thus, the theoretical basis for quantitation of certain aspects of hepatic function are available. It remains to be determined whether these indices will provide clinically useful measures to follow the natural history of hepatic disease.This publication has 45 references indexed in Scilit:
- Further Observations on Relationships between Antipyrine Half-life, Clearance and Volume of DistributionClinical Pharmacokinetics, 1980
- Hepatic Disease and Drug PharmacokineticsClinical Pharmacokinetics, 1980
- The relationship between conventional liver tests, quantitative function tests, and histopathology in cirrhosisDigestive Diseases and Sciences, 1979
- Drug Kinetics and Hepatic Blood FlowClinical Pharmacokinetics, 1979
- Assessment of the (14C) aminopyrine breath test in liver disease.Gut, 1978
- The Influence of Cirrhosis on Steady-State Blood Concentrations of Unbound Propranolol after Oral Administration1Clinical Pharmacokinetics, 1978
- Pharmacokinetics of Lorcainide in ManClinical Pharmacokinetics, 1978
- Propranolol Disposition in Chronic Liver DiseaseClinical Pharmacokinetics, 1976
- Clearance concepts in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- PERSISTENCE OF ANTIBIOTICS IN BLOOD OF PATIENTS WITH ACUTE RENAL FAILURE. II. CHLORAMPHENICOL AND ITS METABOLIC PRODUCTS IN THE BLOOD OF PATIENTS WITH SEVERE RENAL DISEASE OR HEPATIC CIRRHOSIS*†Journal of Clinical Investigation, 1959